Nucleic Acid Therapeutics Core
Advancing the next generation of nucleic acid–based therapies to accelerate science and transform patient care.
The Nucleic Acid Therapeutics Core (NATx Core) is a cross-campus platform for the design, synthesis, and testing of gene-targeted nucleic acid modulators. Our mission is to accelerate precision medicine by making cutting-edge tools and providing expertise to every investigator—and every patient—who needs them. From rare genetic disorders to more common diseases, we aim to reduce barriers, foster collaboration, and make Michigan a national leader in nucleic acid–based therapy development.
Visit us in our new space in the Life Sciences Institute: https://myumi.ch/lsi-NATx
Principal Investigator
Michelle L Hastings
Pfizer Upjohn Research Professor of Pharmacology
Professor of Pharmacology
Medical School
Professor of Medicinal Chemistry
College of Pharmacy
Professor of Pharmacology
Medical School
Professor of Medicinal Chemistry
College of Pharmacy
